Latest News

Greenfern Industries’ GMP medicine prescription sales in the Australian market are going from strength to strength. Read more ...

Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand ...

Julie Curphey has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company. Prior ...

Helius was New Zealand’s first medicinal cannabis business to achieve a GMP Licence for Manufacturing Medicines in July 2021, covering the ...

Rua is one of just two companies in New Zealand manufacturing medicinal cannabis that has met the minimum quality standards as ...

Helius Therapeutics has launched a collaboration with the University of Canterbury (UC) to test how accurately conditions such as stress ...

A partnership between the Government and Marlborough-based medicinal cannabis grower Puro will fast-track New Zealand’s organic medicinal cannabis industry. Managing director Tim ...

Puro has released over 400,000 beneficial bugs to protect their precious plants. One of the key challenges of growing medical cannabis organically ...

Greenfern Industries is the first New Zealand medicinal cannabis company to be awarded B Corp certification gaining an overall finalised score ...

Greenfern Industries Limited (GFI) is about to commence the writing of clinical trial protocols for a low dose CBD medication that ...

Australian Natural Therapeutics Group (ANTG) has been granted approval by the New Zealand ministry of health to import and distribute THC ...

As part of its global strategy, New Zealand medicinal cannabis company Ora Pharm has launched in Australia this week. Ora Pharm ...